Post Publication Amendment

PTO- 1771

Approved for use through 11/30/2023. OMB 0651-0050

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1771

Approved for use through 11/30/2023. OMB 0651-0050

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Post-Approval/Publication/Post-Notice of Allowance (NOA) Amendment

To the Commissioner for Trademarks:

Application serial no. 90262906 TRUSELTIQ(Standard Characters, see http://uspto.report/TM/90262906/mark.png) has been amended as follows:

EXPLANATION OF FILING
Applicant would like to amend the identification of goods and services in classes 5 and 42 in its application to delete the phrase "and skeletal abnormalities" from the identification. The amended identification should read "Class 5:: Pharmaceutical preparations and substances for the treatment of cancer" and Class 42: " Conducting research and development in the fields of cancer"

CLASSIFICATION AND LISTING OF GOODS/SERVICES

Applicant proposes to amend the following:

Current:
Class 005 for Pharmaceutical preparations and substances for the treatment of cancer and skeletal abnormalities
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.


Proposed:

Tracked Text Description: Pharmaceutical preparations and substances for the treatment of cancer and skeletal abnormalities; Pharmaceutical preparations and substances for the treatment of cancerClass 005 for Pharmaceutical preparations and substances for the treatment of cancer
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

Webpage URL: None Provided
Webpage Date of Access: None Provided


Applicant proposes to amend the following:

Current:
Class 042 for Conducting research and development in the fields of cancer and skeletal abnormalities
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.


Proposed:

Tracked Text Description: Conducting research and development in the fields of cancer and skeletal abnormalities; Conducting research and development in the fields of cancerClass 042 for Conducting research and development in the fields of cancer
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

Webpage URL: None Provided
Webpage Date of Access: None Provided

Correspondence Information (current):
      JESSICA L. ROTHSTEIN
      PRIMARY EMAIL FOR CORRESPONDENCE: NY-TM-Admin@goodwinprocter.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jrothstein@goodwinprocter.com; avaccaro@goodwinprocter.com; jnici@goodwinprocter.com

The docket/reference number is 138331273401.
Correspondence Information (proposed):
      Jessica L. Rothstein
      PRIMARY EMAIL FOR CORRESPONDENCE: NY-TM-Admin@goodwinprocter.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jrothstein@goodwinprocter.com; avaccaro@goodwinprocter.com; jnici@goodwinprocter.com

The docket/reference number is 138331273401.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

SIGNATURE(S)

Signature: /Jessica L. Rothstein/     Date: 03/25/2021
Signatory's Name: Jessica L. Rothstein
Signatory's Position: Attorney of record, New York bar member

Signatory's Phone Number: 212-813-8800 Signature method: Signed directly within the form

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    JESSICA L. ROTHSTEIN
   GOODWIN PROCTER LLP
   620 EIGHTH AVENUE
   620 EIGHTH AVENUE
   NEW YORK, New York 10018
Mailing Address:    Jessica L. Rothstein
   GOODWIN PROCTER LLP
   620 EIGHTH AVENUE
   620 EIGHTH AVENUE
   NEW YORK, New York 10018
        
Serial Number: 90262906
Internet Transmission Date: Thu Mar 25 13:56:58 ET 2021
TEAS Stamp: USPTO/PPA-XX.XXX.XX.XX-20210325135658498
708-90262906-770f4b075dc48de535936eaefc1
d76c9aa518d4afe645a27813ac8a1cabc7982fd3
-N/A-N/A-20210325135414768638